NEWSALY™
    A World Of News, One Window.Friday, September 25, 2026
    world

    Estudo da Fiocruz mostra alta adesão à PrEP injetável e menor incidência de HIV

    G1
    September 25, 2026
    via G1

    You're reading one story from Newsaly

    Newsaly brings together 60,000+ newspaper articles, 30,000+ podcasts and 10,000+ magazine articles from around the world.

    A World Of News, One Window.

    Explore Today's News
    Estudo da Fiocruz mostra alta adesão à PrEP injetável e menor incidência de HIV

    Cabotegravir é um medicamento injetável para prevenção do HIV Divulgação Um estudo brasileiro publicado nesta quinta-feira (24) na revista científica The Lancet HIV mostrou que pessoas que usaram o cabotegravir injetável como profilaxia pré-exposição (PrEP) contra o HIV tiveram 90,8% dos dias de aco

    Read the full story

    Explore More On Newsaly

    60,000+ Newspaper Articles

    Explore newspapers from around the world.

    Explore Newspapers

    30,000+ Podcasts

    Discover podcasts and listen to the latest conversations and news.

    Explore Podcasts

    10,000+ Magazine Articles

    Explore magazine articles from around the world.

    Explore Magazines

    Voices (0)

    Share a 15-second voice reaction. Voices automatically disappear after 10 days.

    Sign in to record a voice on this article.

    Be the first to share a voice on this article.